Egyptian middleman identifies Turkey as fake Avastin source; Bayer CEO decries Euro-budget cuts;

@FiercePharma: FDA chides Merck to follow up on post-marketing Januvia study. Testing in rodents for pancreatitis risk--WSJ. News | Follow @FiercePharma

> An Egyptian middleman said Turkey was the source of Avastin vials that he purchased for a client and that later were identified as counterfeit, Reuters reports. News

> Bayer CEO Marijn Dekkers joined the chorus of pharma executives warning that European budget cuts would damper the industry's ability to finance innovation. Report

> Germany's public health funds saved 25% on its 2011 drugs bill thanks to greater use of generics, new industry figures show. Story

> Pfizer ($PFE) recalled one lot of its Prevnar vaccine because it contained active ingredient that had expired, the FDA said. Report

> A U.S. probe into insider trading at hedge funds has widened to include biotech and pharmaceutical stocks, with investigators looking at trades around M&A and drug approvals. More

> France's Ipsen expects thinner operating margins in 2012 as primary care drug sales drop and French price cuts take a bite out of profits. Piece

> PhRMA is calling on officials in U.S. and Korea to implement pricing and reimbursement provisions in the new U.S.-Korea Free Trade Agreement. Story

> A study found that people who use sleeping pills are more likely to die than patients who don't, but the results don't prove they would have died later without the pills. News

Biotech News

@FierceBiotech: Dainippon bags Boston Biomedical and cancer stem cell tech in $2.6B buyout, with $200M upfront and lots of biobucks. News | Follow @FierceBiotech

 @JohnCFierce: Cowen's Simos Simeonidis calls $VVUS raise a "decent insurance policy" against an unexpected setback on approval. Expects approval. | Follow @JohnCFierce

@RyanMFierce: Kudos to Roger Tung of Concert, who told me JPM 2012 that he'd land a new deal soon, and he did it. Not all biotech CEOs deliver like that. | Follow @RyanMFierce

@FierceMedDev: NovaSom moves test for obstructive sleep apnea from the lab to the home. Release | Follow @FierceMedDev

@MarkHFierce: Could proper brain sugar levels manage or prevent Alzheimer's? I don't think they mean the kind of sugar I like. More | Follow @MarkHFierce

> Dutch antibody experts forge rare disease discovery pact with Shire. Item

> C3 Jian raises $30M for dental treatment. Report

> Vivus basks in limelight of rampant M&A speculation. News

> Abbott's deal-team delivers $1.35B Galapagos RA pact. Story

> Dainippon bags Boston Biomedical and cancer stem cell tech in $2.6B buyout. Item

> Concert Pharma snags $200M licensing pact with Avanir. Article

Medical Device News

> Koning gets CE Mark for breast CT system. Item

> Globus, CEO slapped with $1M fine for distributing unapproved device. More

> Was Stryker's MacMillan ousted? Story

Biomarkers News

> Gene-based biomarkers could cut invasive bladder biopsies. Article

> MRI technique may serve as chronic pain biomarker. Item

> The unified theory of biomarkers: Stromedix and Biogen Idec. More

Drug Delivery News

> Iranian researchers test gold nanoparticle cancer drug delivery. More

> Drug delivery nanorockets ricochet riotously. Story

> Biogen Idec secures FDA nod for Avonex delivery accessory. Article

> Forest Labs to launch inhaled lung infection drug in Germany. News

And Finally... Researchers found that people prone to depression have hyper-connected brains. Report